Impax Laboratories (NASDAQ: IPXL) priced $500,000,000 aggregate principal amount of 2.00% convertible senior notes due 2022 (the "notes") in a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE